Predictive Value of the nProfiler 1 Assay for the Efficacy of Adjuvant S-1-Based Doublet Chemotherapy in Stage III Gastric Cancer: A Post-Hoc Analysis of a Randomized Phase III Trial.
Saved in:
| Title: | Predictive Value of the nProfiler 1 Assay for the Efficacy of Adjuvant S-1-Based Doublet Chemotherapy in Stage III Gastric Cancer: A Post-Hoc Analysis of a Randomized Phase III Trial. |
|---|---|
| Authors: | Lee DK; Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea.; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea., Lee CK; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea., Kim HS; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea., Sym SJ; Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea., Zang DY; Division of Hematology-Oncology, Department of Internal Medicine, Hallym University Medical Center, Hallym University College of Medicine, Anyang, Korea., Kim KH; Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea., Lim JH; Department of Internal Medicine, Inha University College of Medicine, Incheon, Korea., Kim HS; Division of Hematology-Oncology, Department of Medicine, Veterans Health Service Medical Center, Seoul, Korea., Lee KH; Division of Hematology and Oncology, Department of Internal Medicine, Yeungnam University Hospital, Yeungnam University College of Medicine, Daegu, Korea., Gee HY; Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea., Rha SY; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea.; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea., Kim H; Department of Pathology, Yonsei University College of Medicine, Seoul, Korea., Jung M; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea. |
| Source: | Cancer research and treatment [Cancer Res Treat] 2025 Jul; Vol. 57 (3), pp. 770-780. Date of Electronic Publication: 2024 Nov 12. |
| Publication Type: | Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial |
| Journal Info: | Publisher: Korean Cancer Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-9256 (Electronic) Linking ISSN: 15982998 NLM ISO Abbreviation: Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
